Gene expression microarray analysis of early oxygen-induced retinopathy in the rat by Tea, Melinda et al.
Gene expression microarray analysis of early
oxygen-induced retinopathy in the rat
Melinda Tea & Rhys Fogarty & Helen M. Brereton &
Michael Z. Michael & Mark B. Van der Hoek &
Anna Tsykin & Douglas J. Coster & Keryn A. Williams
Received: 2 October 2009 /Accepted: 6 November 2009 /Published online: 12 December 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Different inbred strains of rat differ in their
susceptibility to oxygen-induced retinopathy (OIR), an
animal model of human retinopathy of prematurity. We
examined gene expression in Sprague–Dawley (susceptible)
and Fischer 344 (resistant) neonatal rats after 3 days
exposure to cyclic hyperoxia or room air, using Affymetrix
rat Genearrays. False discovery rate analysis was used to
identify differentially regulated genes. Such genes were then
ranked by fold change and submitted to the online database,
DAVID. The Sprague–Dawley list returned the term “re-
sponse to hypoxia,” absent from the Fischer 344 output.
Manual analysis indicated that many genes known to be
upregulated by hypoxia-inducible factor-1α were down-
regulated by cyclic hyperoxia. Quantitative real-time RT-
PCR analysis of Egln3, Bnip3, Slc16a3, and Hk2 confirmed
the microarray results. We conclude that combined method-
ologies are required for adequate dissection of the patho-
physiology of strain susceptibility to OIR in the rat.
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Introduction
Retinopathy of prematurity (ROP) is a blinding condition of
some premature infants who require neonatal intensive care
and supplemental oxygen therapy [1]. Severe retinal disease
affects approximately 5% of these neonates, and despite
best available care, 10–15% will suffer significant visual
impairment [2]. ROP shows variation in incidence, pro-
gression, and disease severity among premature neonates,
and strong evidence exists to indicate a heritable predispo-
sition [2–4]. Thus, in a retrospective study of monozygotic
and dizygotic twins, 70% of the variance in susceptibility to
ROP was found to be the result of genetic factors alone,
even after accounting for the effects of gestational age and
duration of supplemental oxygen [5]. Furthermore, many
studies have identified an influence of ethnicity in suscep-
tibility to ROP [2, 6–8].
The retinae of small rodents and some other mammals
are largely avascular at birth, and retinal vascularization
occurs in the early neonatal period. Neonatal rodents
exposed to hyperoxia and that are then returned to the
relative hypoxia of room air develop rapid, reliable neo-
vascularization and the development of microvessel abnor-
malities that closely resemble human ROP. Models of
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DOI 10.1007/s12177-009-9041-7oxygen-induced retinopathy (OIR) have long informed our
understanding of the pathophysiology of ROP [9]. A
heritable component to ocular angiogenesis has been well
documented [10], and we have shown that inbred strains of
rat exhibit differential susceptibility to OIR [11]. Three
albino strains, Lewis, Fischer 344 (F344), and Wistar–
Furth, were found to be resistant to the effects of hypoxia
following hyperoxic exposure, whereas the albino Sprague–
Dawley (SD) strain was relatively susceptible, and the
pigmented Dark Agouti (DA) strain was very sensitive. The
last two strains develop florid microvascular abnormalities
and neovascular tufts. These differences in susceptibility are
independent of litter size, body mass, arterial oxygen tension,
and major histocompatibility complex haplotype. Genetic
backcross analysis of the susceptibility trait suggested an
autosomal dominant pattern of inheritance in the F344 and
DA strains [12], confirming that susceptibility to OIR in the
rat is a heritable trait. Further, we and others have
demonstrated that disease susceptibility correlates with
differential expression of several angiogenesis-related genes
very early in retinal microvascular development [13, 14].
To identify the pathways responsible for the difference in
retinal vascular phenotype exhibited by different albino rat
strains following exposure to cyclic hyperoxia and subse-
quent hypoxia, we performed an initial screen of retinal
mRNAs from F344 (resistant to OIR) and SD (moderately
susceptible to OIR) at an early time-point (day 3), using the
Affymetrix GeneChip rat arrays covering over 27,000 genes.
Quantitative real-time reverse-transcription polymerase
chain reaction (qRT-PCR) was used to confirm differential
expression of some candidates, and the online Database for
Annotation, Visualization, and Integrated Discovery (DA-
VID) was used for pathway analysis [15, 16].
Materials and methods
Experimental animals
Inbred F344 and SD rats were obtained from the institu-
tional animal facility. Rats were allowed unlimited access to
rat chow and water and were exposed to a 12-h light–dark
cycle. Room temperature was maintained at 24°C. All
animal experimentation was approved by the institutional
Animal Welfare Committee.
Exposure of neonatal rats to cyclic hyperoxia
The oxygen exposure protocol used in this study is a
modification of those used in other studies of OIR in the rat
[17–21]. Within 12 h of birth, female rats and their litters
were placed in a humidified chamber and exposed to
alternating 24-h cycles of hyperoxia (80% oxygen in air)
and normoxia (21% oxygen in air) until the rats were
euthanized [11]. This protocol was chosen because it
reliably induces retinopathy in susceptible strains, without
evidence of systemic toxicity [11]. Age and strain-matched
room air (normoxia)-exposed rats were used as controls.
Retinal dissection and histochemistry
Rats were killed with an inhaled overdose of isoflurane
anesthesia on post-natal day 3 (P3), after the second
24-h exposure to hyperoxia. Retinal dissections and histo-
chemistry labeling were performed as previously described
[11]. Briefly, eyes were enucleated and fixed in 2% weight/
volume paraformaldehyde in phosphate-buffered saline,
pH 7.4 for 90 min on ice. The retinae were dissected, and
four incisions were made to flatten the tissue. Within 6 h of
enucleation, the dissected retinae were stained for 18 h with
fluorochrome-conjugated Griffonia simplicifolia isolectin
B4 (GS-IB4; Alexa Fluor 488 conjugate; Molecular Probes,
Eugene, OR, USA) to highlight the vasculature.
Image analysis of isolectin-labeled retinae
Imaging of labeled retinae was performed within 12 h of
staining. Images were captured using a fluorescence micro-
scope (Olympus Optical Co. Ltd., Tokyo, Japan) attached to a
CCD-digitalcamera(RoperScientific,Trenton,NJ,USA)and
image acquisition software (CoolSNAP, Roper Scientific).
Serial, overlapping high-resolution images of the entire retina
were taken using a ×4 objective lens. Images were then
merged to create a montage (Adobe Photoshop CS3, Adobe
systems Inc., San Jose, CA, USA).
Preparation of RNA
At P3, rats were removed from the oxygen chamber and
euthanized with an inhaled overdose of isoflurane anesthetic.
The eyes were immediately enucleated and placed into
chilled diethylpyrocarbonate (DEPC, Sigma, St. Louis, MO,
USA)-treated saline. Total RNA preparations were made
from whole retinae with the retinal pigment epithelium
attached and snap-frozen in liquid nitrogen. The total time in
normoxia from removal of rat pups from the oxygen
chamber to snap-freezing of the retinae was about 20–
30 min. Tissue handling, thereafter, was kept to a minimum
to prevent RNA degradation. Total RNA was isolated from
pooled retinae of individual rats using TRIzol (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
method. Total RNA was quantified using the Nanodrop
8000 (Thermo Scientific, Wilmington, DE, USA). The
absorbance ratio of the RNA at 260 and 280 nm was used
as a guide in determining RNA purity. Samples with a ratio
of 1.9 or more were considered to be acceptable. RNA
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agarose gel electrophoresis. RNA with a 28S:18S ratio of
approximately 2:1 and minimal DNA contamination was
consideredacceptablefor use.RNAwas further purifiedusing
a Qiagen RNeasy Micro column purification kit (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol.
Preparation of test RNA samples for mRNA
microarray analysis
Retinae from post-natal day-3 rats (P3) were collected for
each experimental condition as shown in Supplemental
Material Fig. S1. Briefly, four experimental conditions were
tested: F344 room air-exposed (RA), F344 cyclic
hyperoxia-exposed (O2), SD RA, and SD O2. For each of
these experimental conditions, total RNA from a minimum
of nine rats from up to three different litters was collected.
A proportion of several RNA samples were used to create a
test pool consisting of three randomly selected rats. RNA
from the remaining rats was used to make a second and
third test sample as required, using RNA from a maximum
of three rats per sample. These acted as biological replicates
for the same experimental conditions.
Affymetrix mRNA microarrays
Samples were analyzed at the Adelaide Microarray Centre
(University of Adelaide and Hanson Institute, South
Australia, Australia). Prior to arraying, samples were
analyzed to determine RNA integrity using the Agilent
Bioanalyser 2100 (Agilent Technologies, Santa Clara, CA,
USA). Samples with a RNA integrity number of seven or
above were deemed suitable for further use in mRNA
microarrays.
Two samples were provided for each of the four
experimental strain/treatment conditions. Sample grouping
was initially assessed using a principal component analysis
(PCA) plot (Partek Genomics Suite) of the corrected data
(Supplemental Material Fig. S2). As a result of the original
PCA, additional samples for F344 O2 and SD RA were
submitted for analysis, and the enhanced dataset was
reanalyzed by PCA (Supplemental Material Fig. S3). A
maximum of three samples were used for each experimental
condition. Single-color arrays allowed for comparisons to
be made among all experimental conditions. A total of six
comparisons were made: F344 versus SD (indifferent to
treatment), O2 versus RA (indifferent to strain), F344 RA
versus SD RA, F344 O2 versus SD O2, F344 O2 versus
F344 RA, and SD O2 versus SD RA.
AffymetrixGeneChipGene1.0STRatArrays(Affymetrix
Inc., Santa Clara, CA, USA) covering 27,342 genes using
722,254 distinct 25-mer oligonucleotide probes were used for
gene expression analysis.
Data analysis of microarrays
Affymetrix raw gene array data were processed using the
Partek Genomics Suite software (Partek Inc., St. Louis, MO,
USA). Briefly, .cel files were imported using RMA back-
ground correction, Partek’s own GC content correction, and
mean probe summarization. Differential gene expression
was assessed by ANOVA with the p value adjusted using
step-up [22] multiple test correction to control the false
discovery rate (FDR). Adjusted p values<0.05 were
considered to be significant.
A bioinformatics approach was used to determine the
biological context of the large amounts of gene expression
data generated by the microarray screen. Gene lists from
comparisons showing significant differences in gene ex-
pression were submitted to the freely available database
DAVID [15, 16]. Pathways showing enrichment for specific
genes were found using the functional annotation chart
pathway-mining tool.
Preparation of cDNA for RT-PCR
One microgram of RNA pools previously prepared for
microarray analysis was DNase-treated with Turbo DNA-
free according to the manufacturer’s instructions (Ambion,
Austin, TX, USA) and reverse-transcribed in 20-μl
reactions using a first-strand cDNA synthesis kit (Super-
Script III First-Strand Synthesis System, Invitrogen). An
RT-free control sample was prepared in parallel with each
cDNA sample, with substitution of DEPC-treated water for
reverse transcriptase. For purposes of standardization, a
standard cDNA pool was prepared from pooled retinal
RNA extracted from 10 F344, SD, and DA rats from a
range of developmental stages that had been exposed to
room air or cyclic hyperoxia. Samples of cDNA were
frozen at −20°C.
Primers for RT-PCR
Primers for candidate genes were designed to flank an
intron using Primer3 software [23] and tested in silico
for specificity against sequences for Rattus norvegicus
using BLAST software (NCBI, Bethesda, MD, USA)
(Table 1). Primers were synthesized by Geneworks Ltd
(Thebarton, South Australia, Australia). Primer pairs
were aligned with the rat genome (NCBI BLAST
software) to identify the potential for genomic DNA
amplification and were considered acceptable if the
genomic amplicon was more than twice the length of
the target cDNA amplicon. Acidic ribosomal phospho-
protein (Arbp) and hypoxanthine guanine phosphoribosyl
transferase (Hprt) were used as housekeeping reference
genes.
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qRT-PCR was performed with reference to the MIQE guide-
lines [24]. Each 20-µl reaction mixture contained 10 µl of
SYBR Green master-mix (Power SYBR Green PCR Master
Mix; Applied Biosystems), 2 µl each forward and reverse
primers (0.5 µM final concentration), and 6 µl cDNA sample
diluted 1/100 with Ultra Pure water (Fisher Biotech, Western
Australia, Australia). Reactions were run on a StepOnePlus
Real-Time PCR System (Applied Biosystems). Cycling
conditions were: initial denaturation (95°C, 10 min) followed
by 40 cycles of denaturation (95°C, 15 s), annealing, and
extension (60°C, 1 min). Candidate genes were tested in
triplicate wells and in duplicate experiments, giving a total of
six replicates for each sample pool per gene. The standard
cDNA pool was included in triplicate in each PCR run. A
single RT-free negative control for each sample and two water
controls (no-template control) were included in each experi-
ment. Melt-curve analysis was used to confirm amplicon
specificity. The melt curve of each PCR product was compared
with that of the corresponding sequenced product. Represen-
tative PCR products of all genes were separated on agarose
gels, purified, sequenced, and compared with the predicted
amplicon sequence to confirm identity. DNA was extracted
from agarose gels using the Qiaquick column purification
system (Qiagen) and eluted in 10 mM Tris–Cl pH 8.5 for
quantificationandsequencing.PurifiedDNAwaslabeledusing
the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems) and resolved using the ABI 3100 Genetic
Analyser (Applied Biosystems).
Analysis of qRT-PCR data
Gene expression in each sample was determined relative to
the standard cDNA pool and normalized to the reference
genes Arbp and Hprt using the method of Vandesompele et
al [25]. Arbp and Hprt are stably expressed under con-
ditions of cyclic hyperoxia and during early development in
a number of rat strains [26].
Results
Retinal vascularization in post-natal day-3 rats exposed
to cyclic hyperoxia
Montages of representative sectors from the retinae of
3-day-old F344 and SD rats exposed to cyclic hyperoxia
from birth or raised in room air are shown in Fig. 1. During
normal retinal vascular development, vessels develop from
the optic nerve head (indicated by arrow) towards the
peripheral retina. At post-natal day 3, vessels in the room
air-exposed and cyclic hyperoxia-exposed F344 rats, and in
the room air-exposed SD rats, had begun to develop and
showed normal morphology (Fig. 1a–c). SD rats exposed to
cyclic hyperoxia showed aberrant vascular development,
with fewer vessels radiating from the optic nerve head and
reduced density of the capillary network (Fig. 1d).
Changes in gene expression in response to cyclic hyperoxia
exposure and/or strain
The Affymetrix microarrays were used to investigate changes
in gene expression in response to cyclic hyperoxia exposure
and/or strain. The FDR represents the number of false positives
that may be present within the dataset. The number of genes
that were significantly overexpressed or underexpressed in each
comparison is shown in Table 2 at a FDR of 5%. The majority
of significant differences in gene expression were observed
between strains. When the false discovery rate was set at 10%
or 20%, no differences were found in gene expression relating
to both strain and treatment combined (data not shown).
Table 1 Primer sequences for qRT-PCR
Gene (accession number) Primer sequence (5′–3′) Nucleotide
position
Amplicon size (bp)
EGL nine homolog 3 TTGGGACGCCAAGTTACATG (for) 1003–1078 76
(Egln3) (NM 019371.1) GGGCTCCACGTCTGCTACAA (rev)
BCL2/adenovirus E1B 19 kDa-interacting protein 3 GCGCACAGCTACTCTCAGCA (for) 478–627 150
(Bnip3) (NM 053420.2) GTCAGACGCCTTCCAATGTAGA (rev)
Solute carrier family 16, member 3 ATGTGTGTGAACCGCTTTGG (for) 327–449 123
(Slc16a3) (NM 030834.1) GACCCCTGTGGTGAGGTAGATC (rev)
Hexokinase 2 CAACATTCTCATCGATTTCACGAA (for) 2463–2607 145
(Hk2) (NM 012735.1) GATGGCACGAACCTGTAGCA (rev)
Acidic ribosomal phosphoprotein AAAGGGTCCTGGCTTTGTCT (for) 766–856 91
(Arbp) (NM 022402.1) GCAAATGCAGATGGATCG (rev)
Hypoxanthine guanine phosphoribosyl transferase TTGTTGGATATGCCCTTGACT (for) 629–733 105
(Hprt) (NM 012583.2) CCGCTGTCTTTTAGGCTTTG (rev)
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rats showed 251 genes to be significantly regulated by
strain at p<0.05 (adjusted for the number of comparisons;
see Supplemental Material Table S1 for entire list). The top
20 differentially regulated genes are shown in Table 3.
Using DAVID, genes related to strain were found to be
involved in processes such as peptide transport, cell
localization, immune response, and nervous system devel-
opment (Table 4). When room air exposure was taken into
consideration, 11 genes were found to be significantly
differentially regulated in their fold changes (Table 5).
A comparison of treatment groups (cyclic hyperoxia and
room air-exposed rats), irrespective of strain, showed minimal
fold changes in gene expression, and adjusted p values
indicated the fold changes were insignificant (Supplemental
Material Table S2). A comparisonof cyclic hyperoxia-exposed
F344 and SD rats showed that ten genes were differentially
expressed to a significant extent (Table 6). The majority of
these genes were represented in the previous comparisons.
No significant changes in gene expression were seen in
F344 rats exposed to cyclic hyperoxia for 3 days compared
to room air-exposed rats (Supplemental Material Table S3).
Similarly, no significant changes were observed in cyclic
hyperoxia-exposed SD rats compared with room air-
exposed controls (Supplemental Material Table S4). Ad-
justed p values were greater than 0.05. The entire
Affymetrix microarray dataset can be found in Supplemen-
tal Material Table S5. The dataset has also been deposited
in NCBI's Gene Expression Omnibus and is accessible
through GEO Series accession number GSE18998 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18998).
Fold change analysis of differentially regulated genes
In each of the six comparisons, the number of genes that
showed a change of at least 1.5-fold accounted for 1.3 % or
less of the total number of genes represented on the
Fig. 1 Montages of
representative sectors of retinae
of room air-exposed and cyclic
hyperoxia-exposed rats collected
at post-natal day 3 and stained
with fluorochrome-conjugated
GS-IB4 to highlight the vascu-
lature. a F344 rat raised in room
air; b F344 rat exposed to cyclic
hyperoxia from birth; c SD rat
raised in room air; d SD rat
exposed to cyclic hyperoxia
from birth
Table 2 False discovery rate report with significance levels set at 5%
Experimental condition Number of gene with
significant p values
p Value (Strain; F344 versus SD) 251
p Value (Treatment; O2 versus RA) 0
p Value (Strain * Treatment) 0
p Value (F344 O2 versus SD O2)1 0
p Value (F344 RA versus SD RA) 11
p Value (F344 O2 versus F344 RA) 0
p Value (SD O2 versus SD RA) 0
Total number of p values=27,342
O2 exposed to cyclic hyperoxia; RA exposed to room air
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genes reached statistical significance in the initial micro-
array analysis, an alternative approach was used. For each
strain, genes that differed between cyclic hyperoxia and
room air-treated groups were ranked by fold change. The
top 50 upregulated and downregulated genes were submit-
ted to DAVID to identify enriched gene groups (Table 8)
[15, 16]. Genes from both strains were enriched for Gene
Ontology (GO) terms related to carbohydrate metabolism.
Many more of these terms appeared in the SD list compared
to the F344 list. The SD list showed strong enrichment for
genes involved in glycolysis, a process that is known to be
affected by oxygen levels. In addition, the SD list returned
the GO term “Response to Hypoxia” which was absent
from the F344 output.
Manual analysis of the gene lists showed that many
genes known to be upregulated by hypoxia-inducible
factor-1α (Hif-1α) were present (Table 9) and were almost
exclusively downregulated by cyclic hyperoxia, the inverse
response of these genes to hypoxia. The SD list contained
almost twice as many Hif-1α-regulated genes as the F344
list. Those in the SD list were more strongly regulated by
cyclic hyperoxia and represented 18 of the top 20 down-
regulated genes, compared with seven of the top 20
downregulated genes in the F344 list. qRT-PCR analysis
of expression levels for Egln3, Bnip3, Slc16a3, and Hk2
Table 3 Top 20 of 251 genes significantly regulated by strain
Gene Gene description Fold change Fold change description Adj. p value
Mospd1
a Motile sperm domain containing 1 22.11 F344 up vs. SD 0.002
RGD1564739 Akin to spermatogenesis-associated glutamate (E)-r −3.62 F344 down vs. SD 0.002
Ly6g6e Lymphocyte antigen 6 complex, locus G6E 3.84 F344 up vs. SD 0.002
Slc26a7 Solute carrier family 26, member 7 −4.42 F344 down vs. SD 0.002
Hey2 Hairy/enhancer-of-split related to YRPW motif 2 1.27 F344 up vs. SD 0.003
Tap2 Transporter 2, ATP-binding cassette, sub-family B 5.60 F344 up vs. SD 0.003
10722435
b Unknown −19.64 F344 down vs. SD 0.005
Stk32a Serine/threonine kinase 32A −5.33 F344 down vs. SD 0.005
RGD1562660 RGD1562660 −1.30 F344 down vs. SD 0.006
RGD1560289 Similar to chromosome 3 open reading frame 20 −2.38 F344 down vs. SD 0.008
Arsb Arylsulfatase B −2.50 F344 down vs. SD 0.008
RT1-Bb RT1 class II, locus Bb −3.59 F344 down vs. SD 0.008
Ly6g6d Lymphocyte antigen 6 complex, locus G6D 3.50 F344 up vs. SD 0.010
10804316
b Unknown −1.72 F344 down vs. SD 0.010
Oprk1 Opioid receptor, kappa 1 2.00 F344 up vs. SD 0.010
10824257
b Unknown 2.69 F344 up vs. SD 0.010
Ank2 Ankyrin 2, neuronal −1.27 F344 down vs. SD 0.011
10724713
b Unknown −1.76 F344 down vs. SD 0.011
Fgd3 FYVE, RhoGEF and PH domain containing 3 2.32 F344 up vs. SD 0.011
10900112
b Unknown −3.56 F344 down vs. SD 0.011
Adjusted p value<0.05; ± indicates overexpression or underexpression of the gene, respectively. For the entire gene list, see Supplemental
Material Table S1
aGene is represented by a second exon in the array with a fold change of 17.45 and an adjusted p value of 0.002
bAffymetrix probeset ID of a gene which has not been identified
Table 4 DAVID analysis for Gene Ontology terms enriched in the strain comparison ranked by fold enrichment
GO term Number of genes Fold enrichment
a False discovery rate
b
Peptide transport 6 14.2 0.1107
Cell localization 10 3.4 4.5728
Immune response 11 2.9 8.7035
Nervous system development 16 2.8 0.9572
aThe ratio between the frequency of term-annotated genes in the query gene list compared to the reference gene list, in this case the rat genome
bThe expected percentage of false positives in a given proportion of genes considered to be significant
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microarray analysis confirmed the strain-dependent differ-
ence in regulation of these genes by hyperoxia. Fold
changes measured by qPCR for both strains were greater
than those seen in the microarray results and all four
candidate genes were downregulated in both strains in
response to cyclic hyperoxia exposure. A substantially
greater inhibition of gene expression was seen in SD rats
compared to F344 rats.
Discussion
Animal models of ROP [19] aim to recreate the biphasic
progression of the disease seen in humans [27]. In our rat
model, phenotypic changes representative of OIR are
maximal among strains at post-natal day 14 [11], at which
time SD rats show large retinal avascular areas indicative of
susceptibility to OIR, whereas retinal avascular areas in
F344 rats are small, indicating resistance to the disease
[13]. At post-natal day 3, the retinae of room air- and cyclic
hyperoxia-exposed F344 rats and room air-exposed SD rats
showed normal morphology. However, cyclic hyperoxia-
exposed SD rats showed aberrant vascular development,
suggesting that the phenotypic changes reflecting differen-
tial susceptibility to OIR begin to manifest as early as post-
natal day 3. We would, thus, expect the phenotypic changes
to be driven by changes in gene expression.
Our rationale for examining gene changes at the early
time point of day 3 was to increase the likelihood of
identifying gene pathways related to the underlying genetic
cause of phenotypic differences between strains. An
Table 5 Genes significantly regulated (adjusted p value<0.05) by strain in room air-exposed F344 and SD rats
Gene Gene description Fold change Fold change description Adj. p value
Mospd1
a Motile sperm domain containing 1 22.43 F344 RA up vs. SD RA 0.015
RGD1564739 Akin to spermatogenesis associated glutamate (E)-r −3.98 F344 RA down vs. SD RA 0.015
Slc26a7 Solute carrier family 26, member 7 −4.10 F344 RA down vs. SD RA 0.022
Ly6g6e Lymphocyte antigen 6 complex, locus G6E 3.25 F344 RA up vs. SD RA 0.026
Tap2 Transporter 2, ATP-binding cassette, sub-family B 5.56 F344 RA up vs. SD RA 0.029
Hey2 Hairy/enhancer-of-split related with YRPW motif 2 1.23 F344 RA up vs. SD RA 0.035
10722435
b Unknown −20.69 F344 RA down vs. SD RA 0.035
Stk32a Serine/threonine kinase 32A −4.99 F344 RA down vs. SD RA 0.041
Oprk1 Opioid receptor, kappa 1 2.34 F344 RA up vs. SD RA 0.041
Arsb Arylsulfatase B −2.66 F344 RA down vs. SD RA 0.048
RGD1310110 Similar to 3632451O06 Rik protein −1.44 F344 RA down vs. SD RA 0.048
± indicates over- or underexpression of the gene, respectively
aGene is represented by a second exon in the array with a fold change of 17.45 and an adjusted p value of 0.015
bAffymetrix probeset ID of a gene which has not been identified
Table 6 Genes significantly regulated (adjusted p value<0.05) by strain in cyclic hyperoxia-exposed (O2) F344 and SD rats
Gene Gene description Fold change Fold change description Adj. p value
Mospd1
a Motile sperm domain containing 1 21.80 F344 O2 up vs. SD O2 0.012
Ly6g6e Lymphocyte antigen 6 complex, locus G6E 4.55 F344 O2 up vs. SD O2 0.012
Slc26a7 Solute carrier family 26, member 7 −4.77 F344 O2 down vs. SD O2 0.012
Hey2 Hairy/enhancer-of-split related with YRPW motif 2 1.32 F344 O2 up vs. SD O2 0.012
RGD1564739 Akin to spermatogenesis associated glutamate (E)-r −3.30 F344 O2 down vs. SD O2 0.016
Tap2 Transporter 2, ATP-binding cassette, sub-family B 5.64 F344 O2 up vs. SD O2 0.024
10722435
b Unknown −18.64 F344 O2 down vs. SD O2 0.033
Stk32a Serine/threonine kinase 32A −5.69 F344 O2 down vs. SD O2 0.033
RGD1562660 RGD1562660 −1.33 F344 O2 down vs. SD O2 0.033
RGD1560289 Similar to chromosome 3 open reading frame 20 −2.50 F344 O2 down vs. SD O2 0.042
± indicates over- or underexpression of the gene, respectively
aGene is represented by a second exon in the array with a fold change of 17.46 and an adjusted p value of 0.012
bAffymetrix probeset ID of a gene which has not been identified
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retinal mRNAs that are potentially involved in the develop-
ment of OIR. The dataset presented herein identifies changes
in gene expression as a result of strain, cyclic hyperoxia
exposure, and a combination of the two. A limitation of this
study is that rats were inevitably exposed to a brief period of
normoxia (up to 20–30 min), following their removal from
the hyperoxic environment. This may have resulted in
alteration of the expression profiles of some genes; however,
candidate genes were still able to be identified.
At the early time-point of P3, the majority of genes
showing significant differential expression were as a result
of strain alone. Of particular interest were genes which
were differentially expressed as a result of strain and cyclic
hyperoxia exposure because these differences may be
causative of changes seen in the phenotype of rats with
oxygen-induced retinopathy. Functional annotation of the
top 50 genes (based on fold changes) that were upregulated
or downregulated by cyclic hyperoxia in either strain
identified a number of genes which are known to be
regulated by Hif-1α. Differential expression of four genes:
Egln3, Bnip3, Slc16a3, and Hk2 were selected for
confirmation by qRT-PCR on RNA pools identical to those
used in the Affymetrix microarray. Changes in gene
Table 7 Number of genes differentially expressed in the retina, based on fold changes irrespective of up- or downregulation of the gene
Comparison Total number
of genes
No. genes changed
<1.5-fold
No. genes changed
>1.5-fold
No. genes changed
>2-fold
No. Genes changed
>3-fold
F344 vs. SD (strain) 27,342 27,145 (99.3%) 141 (0.5%) 41 (0.1%) 15 (0.1 %)
O2 vs. RA (treatment) 27,342 27,309 (99.9%) 31 (0.1%) 2 (0.0%) 0 (0.0%)
F344 RA vs. SD RA 27,342 27,016 (98.8%) 269 (1.0%) 42 (0.2%) 15 (0.1%)
F344 O2 vs. SD O2 27,342 27,105 (99.1%) 168 (0.6%) 51 (0.2%) 18 (0.1%)
F344 O2 vs. F344 RA 27,342 27,293 (99.8%) 47 (0.2%) 2 (0.0%) 0 (0.0%)
SD O2 vs. SD RA 27,342 27,259 (99.7%) 70 (0.3%) 11 (0.0%) 2 (0.0%)
Percentages of genes changed are shown in brackets
Table 8 DAVID analysis for Gene Ontology terms enriched in the top 50 genes (ranked by fold change) that were up- or downregulated by cyclic
hyperoxia in each strain
GO term Number of genes Fold enrichment
a False Discovery Rate
b
F344
Cellular carbohydrate catabolic process 8 9.6 0.033
Carbohydrate catabolic process 8 9.1 0.049
SD
Glycolysis 8 18.6 3.72E-04
Glucose catabolic process 8 15.9 0.0011
Response to hypoxia 8 15.6 0.0013
Hexose catabolic process 8 15.2 0.0015
Monosaccharide catabolic process 8 15.2 0.0015
Alcohol catabolic process 8 14.7 0.0019
Cellular carbohydrate catabolic process 8 11.8 0.0083
Glucose metabolic process 9 11.4 0.0019
Carbohydrate catabolic process 8 11.1 0.0122
Monosaccharide metabolic process 11 11.0 8.62E-05
Hexose metabolic process 10 10.1 9.22E-04
Soluble fraction 9 7.3 0.0378
Alcohol metabolic process 12 7.1 0.0013
Cellular carbohydrate metabolic process 12 6.9 0.0018
Carbohydrate metabolic process 13 5.3 0.0072
GO terms are ranked by fold enrichment
aThe ratio between the frequency of term-annotated genes in the query gene list compared to the reference gene list, in this case the rat genome
bThe expected percentage of false positives in a given proportion of genes considered to be significant
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Genes downregulated by hyperoxia in F344 rats
Adra1b Adrenergic, alpha-1B-, receptor −2.12
Igfbp2 Insulin-like growth factor binding protein 2 −1.86
Slc16a3 Solute carrier family 16, member 3 −1.86
Cox4i2 Cytochrome c oxidase subunit IV isoform 2 −1.58
Genes downregulated by hyperoxia in SD rats
Slc16a3 Solute carrier family 16, member 3 −4.10
Igfbp2 Insulin-like growth factor binding protein 2 −3.42
Hk2 Hexokinase 2 −2.95
Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 −2.80
Egln3 EGL nine homolog 3 −2.79
Bnip3 BCL2/adenovirus E1B 19 kDa-interacting protein 3 −2.63
Cox4i2 Cytochrome c oxidase subunit IV isoform 2 −2.45
Pdk1 Phosphoglycerate kinase 1 −2.31
Vegfa Vascular endothelial growth factor A −2.23
P4ha1 Procollagen-proline, 2-oxoglutarate 4-dioxygenase −2.20
Mif Macrophage migration inhibitory factor −2.01
Ak3l1 Adenylate kinase 3-like 1 −1.97
Pfkl Phosphofructokinase, liver −1.93
Tpi1 Triosephosphate isomerase 1 −1.89
Egln1 EGL nine homolog 1 −1.72
Bhlhb2 Basic helix-loop-helix family, member e40 −1.67
Ldha Lactate dehydrogenase A −1.62
Pgk1 Phosphoglycerate kinase 1 −1.61
Aldoa Aldolase A, fructose-bisphosphate −1.57
Gpi Glucose phosphate isomerase −1.56
Table 9 Known hypoxia-
regulated genes identified from
the top fifty genes (ranked by
fold change) that were down-
regulated by cyclic hyperoxia in
each strain compared to room
air exposure
Only genes downregulated by
1.5-fold or greater are shown
Fig. 2 RT-PCR quantification
of retinal gene expression in
cyclic hyperoxia-treated and
untreated F344 and SD rats at
post-natal day 3. a Egln3; b
Bnip3; c Slc16a3; d Hk2.
Quantification was performed
on RNA pools identical to those
used in the microarray analysis.
Expression levels were
normalized to the reference
genes Arbp and Hprt. Numbers
above the bars are fold inhibi-
tion by hyperoxia. Error bars ±
standard deviation. *p<0.05
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Egln3 encodes PHD3, a member of the prolyl hydrox-
ylase family of oxygen-dependent enzymes [28]. Hydrox-
ylation of specific proline residues in HIF-1α by prolyl
hydroxylases mediates the binding of the tumor suppressor
protein von Hippel-Lindau to target HIF-1α for ubiquiti-
nylation and proteasomal degradation [28, 29]. Prolyl
hydroxylation is the main mechanism by which HIF-α
levels are regulated in response to hypoxia [30]. There are
three prolyl hydroxylases: PHD1, PHD2, and PHD3, all of
which have been shown to have different functions in
regulating HIF-1α and HIF-2α at the post-transcriptional
level [31]. A study by Appelhoff et al. showed variation in
the expression of prolyl hydroxylases in different human
cell lines exposed to normoxia [31]. PHD2 was found to be
the most abundantly expressed prolyl hydroxylase. Expres-
sion of PHD1 remained unchanged or significantly de-
creased upon exposure to hypoxia. PHD2 and, in particular,
PHD3 were found to be greatly increased by hypoxia.
PHD3 was shown to regulate HIF-2α to a greater extent
than HIF-1α. The ability of PHD3 to remain active under
hypoxic conditions suggests it may play a role in the
physiological regulation of HIF, in particular HIF-2α. The
activity of each prolyl hydroxylase appears to be dependent
on the relative abundance of the other prolyl hydroxylases
present under a specific set of conditions, adding to the
complexity of HIF-α regulation [31].
The oxygen-dependent regulation of HIF-α levels by
prolyl hydroxylases was identified as a pathway of interest.
Egln3 contains a hypoxia response element, allowing its
induction by hypoxia to occur through a HIF-dependent
negative feedback loop [32]. Studies of Hif-2α knockdown
mice with OIR show an absence of neovascularization,
eventually resulting in the degeneration of the neural layers
of the retina due to poor vascularization [33]. The
importance of HIF-2α in retinal angiogenesis has been
supported by another study involving mice with only one
functional Hif-2α gene, in which retinal neovascularization
was reduced in response to cyclic-hyperoxia exposure, due
in part to an absence of pro-angiogenesis factors required to
promote an angiogenic response [34]. At post-natal day 3,
Egln3 was found to be decreased 5.1-fold in SD rats in
response to cyclic hyperoxic exposure. Egln3 was de-
creased to a lesser extent (2.1-fold) in cyclic hyperoxia-
exposed F344 rats compared to room air-exposed rats. In a
recent study by Recchia and colleagues, both rat and mouse
models of OIR were examined at early and late time points
of disease progression [35]. At the early time points of P15
(rat) and P13 (mouse), an increase in Egln3 of 2.5- and 3.5-
fold, respectively, was observed. At the later time points of
P20 (rat) and P18 (mouse), Egln3 expression increased by
3.0- and 5.3-fold, respectively. These increases in Egln3
expression may be a result of the response to relative
hypoxia, particularly at the later time point of OIR, rather
than in response to hyperoxic exposure.
A decrease in Egln3, as observed in our study, might be
expected to result in the stabilization of HIF-1α and
increased expression of genes regulated by transcription
factors, such as VEGF; however, Affymetrix data showed
that VEGF was decreased 2.2-fold in SD rats in response to
cyclic hyperoxia compared to room air exposure. Any
stabilization of HIF-1α expression in the retina in response
to hyperoxia exposure is difficult to determine because
under normoxic conditions, HIF-1α is rapidly degraded by
the ubiquitin proteasome pathway and has a half-life of less
than 5 min [30, 36, 37], and downstream processing of
retinae in normoxia following removal of neonates from a
hyperoxic environment takes 20–30 min. The levels of the
prolyl hydroxylases in response to hyperoxia exposure may
potentially be able to be used as surrogate markers for HIF-
1α in future studies.
Bnip3, expression of which was decreased 3.6-fold in
cyclic hyperoxia-exposed SD rats at post-natal day 3, is a
member of the Bcl-2 family of proteins that play a role in
apoptosis [38]. To our knowledge, expression in the retina
has not previously been reported. However, Hif-1α mediated
overexpression of Bnip3 in response to hypoxia is known to
exert a proapoptotic effect in human kidney epithelial cells
[39]. Slc16a3 is involved in the transport of monocarbox-
ylates such as pyruvate and lactate across cell membranes
and is known to be expressed in ocular tissues including the
retina [40, 41]. Slc16a3, downregulated 4.7-fold in oxygen-
exposed F344 rats and 6.2-fold in oxygen-exposed SD rats,
helps to export lactate, the end product of glycolysis, rapidly
out of retinal cells and prevent intracellular acidosis [40]. It
has been hypothesized that loss of Slc16a3 and other
monocarboxylate transporters may compromise glucose
metabolism and result in abnormalities in retinal function
and retinal degeneration [42]. Hk2, downregulated 4.5-fold
in oxygen-exposed SD rats, is involved in glycolysis and has
previously been reported to be upregulated by hypoxia [43].
We have previously shown that the temporal expression
of pro-angiogenic and anti-angiogenic factors contributes to
susceptibility of different strains of rats to OIR [13]. A
correlation between disease susceptibility and differential
gene expression during early retinal vascular development
as a consequence of cyclic hyperoxia exposure, rather than
exposure to prolonged periods of hypoxia, was observed.
Similarly in a murine model of OIR, Sato et al. showed a
correlation between gene expression patterns and disease
progression [44]. Analysis of gene expression at a late time
point showed that genes associated with angiogenesis were
upregulated in response to a sustained period of hyperoxia,
coinciding with increased vascular development, consistent
with our previous findings.
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at early time points in OIR. Natoli and colleagues examined
the temporal gene expression patterns in mice exposed to
sustained periods of hyperoxia [45]. They found that after
3 days of exposure to hyperoxia, the early response gene
Oxr1 was upregulated in C57BL/6J mice susceptible to
hyperoxia whereas no regulation of Oxr1 was observed in
hyperoxia-resistant BALB/cJ mice. In our studies, no
significant changes in Oxr1 gene expression were observed
as a result of strain or cyclic hyperoxia exposure at post-
natal day 3.
Using Affymetrix arrays as a screening tool to
identify which genes, if any, were likely to be involved
in susceptibility to OIR, we observed that most genes
were not significantly differentially expressed, following
correction for multiple comparisons. An alternative
method for identifying genes of interest was thus
required after the initial microarray screen. We chose to
use fold changes as an indication of differential gene
expression rather than adjusted p values and arbitrarily
chose the top 50 genes found to be upregulated or
downregulated in each strain following cyclic hyperoxia
exposure. Most of these genes showed a fold change of
1.5-fold or more. A bioinformatics approach was then
taken to examine the biological contexts of these changes
in gene expression.
Analysis of gene lists using DAVID highlighted a strong
enrichment for known hypoxia-responsive genes in SD rats,
which was much less evident in F344 rats. This suggests
that differences in one or more of these genes may
contribute to the strain-specific response to cyclic hyper-
oxia. Almost all of the hypoxia-responsive genes identified
were downregulated by cyclic hyperoxia, the inverse of
their response to hypoxia. Sears et al. have shown that the
vaso-obliterative effects of cyclic hyperoxia on retinal
vessels can be negated by inducing a pseudo-hypoxic
environment through inhibition of prolyl hydroxylases,
resulting in stabilization of HIF-1α [46]. An attenuated
response to cyclic hyperoxia in F344 rats may be
responsible for a similar outcome. Another possibility is
that alterations in oxygen sensing pathways in SD rats
exposed to cyclic hyperoxia may be contributing to
susceptibility to OIR. The potential role of differential
ischemic preconditioning in different strains is unknown.
Examining the temporal expression of the candidate genes
by qRT-PCR or a proteomics approach may give a greater
insight into the kinetics of OIR and identify gene
expression patterns which may contribute to susceptibility
to OIR in rats.
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